Overvaluation Will Exacerbate Catastrophe Risks And Insurtech Pressures

Published
20 Aug 24
Updated
07 Aug 25
AnalystConsensusTarget's Fair Value
US$162.00
7.3% undervalued intrinsic discount
07 Aug
US$150.13
Loading
1Y
18.3%
7D
0.3%

Author's Valuation

US$162.0

7.3% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 7.19%

Shared on30 Apr 25
Fair value Increased 3.50%

AnalystConsensusTarget has increased revenue growth from 3.9% to 5.9%.

Shared on23 Apr 25
Fair value Increased 0.43%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 4.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Decreased 2.08%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 2.16%

AnalystConsensusTarget has decreased revenue growth from -1.2% to 3.9% and decreased future PE multiple from 37.2x to 31.2x.